Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 190

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States

Open access
Gaglani, Manjusha, Pruszynski, Jessica, Murthy, Kempapura, Clipper, Lydia, Robertson, Anne, Reis, Michael, Chung, Jessie R., Piedra, Pedro A., Avadhanula, Vasanthi, Nowalk, Mary Patricia, Zimmerman, Richard K., Jackson, Michael L., Jackson, Lisa A., Petrie, Joshua G., Ohmit, Suzanne E., Monto, Arnold S., McLean, Huong Q., Belongia, Edward A., Fry, Alicia M., Flannery, Brendan · 2016 · Journal of Infectious Diseases

Abstract

BACKGROUND: The predominant strain during the 2013-2014 influenza season was 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09). This vaccine-component has remained unchanged from 2009. METHODS: The US Flu Vaccine Effectiveness Network enrolled subjects aged ≥6 months with medically attended acute respiratory illness (MAARI), including cough, with illness onset ≤7 days before enrollment. Influenza was confirmed by reverse-transcription polymerase chain reaction (RT-PCR). We determined the effectiveness of trivalent or quadrivalent inactivated influenza vaccine (IIV) among subjects ages ≥6 months and the effectiveness of quadrivalent live attenuated influenza vaccine (LAIV4) among children aged 2-17 years, using a test-negative design. The effect of prior receipt of any A(H1N1)pdm09-containing vaccine since 2009 on the effectiveness of current-season vaccine was assessed. RESULTS: We enrolled 5999 subjects; 5637 (94%) were analyzed; 18% had RT-PCR-confirmed A(H1N1)pdm09-related MAARI. Overall, the effectiveness of vaccine against A(H1N1)pdm09-related MAARI was 54% (95% confidence interval [CI], 46%-61%). Among fully vaccinated children aged 2-17 years, the effectiveness of LAIV4 was 17% (95% CI, -39% to 51%) and the effectiveness of IIV was 60% (95% CI, 36%-74%). Subjects aged ≥9 years showed significant residual protection of any prior A(H1N1)pdm09-containing vaccine dose(s) received since 2009, as did children <9 years old considered fully vaccinated by prior season. CONCLUSIONS: During 2013-2014, IIV was significantly effective against A(H1N1)pdm09. Lack of LAIV4 effectiveness in children highlights the importance of continued annual monitoring of effectiveness of influenza vaccines in the United States.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jiv577

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 190

Metadata

Authors
Gaglani, M., Pruszynski, J., Murthy, K., Clipper, L., Robertson, A., Reis, M., Chung, J. R., Piedra, P. A., Avadhanula, V., Nowalk, M. P., Zimmerman, R. K., Jackson, M. L., Jackson, L. A., Petrie, J. G., Ohmit, S. E., Monto, A. S., McLean, H. Q., Belongia, E. A., Fry, A. M., & Flannery, B.
Venue
Journal of Infectious Diseases
Published
2016-01-06
Volume
213
Issue
10
Pages
1546-1556
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2301625675
Cited by
190
References
3
FWCI
28.08
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States. https://app.cochat.ai/papers/10.1093/infdis/jiv577
The paper
Gaglani, M., Pruszynski, J., Murthy, K., Clipper, L., Robertson, A., Reis, M., Chung, J. R., Piedra, P. A., Avadhanula, V., Nowalk, M. P., Zimmerman, R. K., Jackson, M. L., Jackson, L. A., Petrie, J. G., Ohmit, S. E., Monto, A. S., McLean, H. Q., Belongia, E. A., Fry, A. M., & Flannery, B. (2016). Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiv577

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.